Skip to content

A Cliniclal Trial on the Value of Bleeding Risk Assessment System in the Treatment of Early Cesarean Scar Pregnancy

A Cliniclal Trial on the Value of Bleeding Risk Assessment System in the Treatment of Early Cesarean Scar Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041654
Enrollment
Unknown
Registered
2021-01-01
Start date
2021-02-28
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean scar pregnancy

Interventions

A1:High-risk induced abortion under B-ultrasound
A2:High-risk induced abortion under B-ultrasound after uterine artery embolization
B1:High-risk induced abortion under B-ultrasound
B2:High-risk induced abortion under B-ultrasound after uterine artery embolization
C1:High-risk induced abortion under B-ultrasound
C2:High-risk induced abortion under B-ultrasound after uterine artery embolization
C3:Hysteroscopy and laparoscopic resection

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All the patients should in early pregnancy with menopause less than 13 weeks; 2. All the patients must be at least over 18 years; 3. All the patients are diagnosed with caesarean scar pregnancy in the first trimester of gestation by ultrasound followed by the guideline; 4. The conditions of caesarean scar pregnancy in women are stable without vaginal bleeding and all the patients do not need for emergence surgery; 5. All the patients want to terminate their pregnancy; 6. Given written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other complications of gynaecological diseases; 2. Patients who need emergence surgery; 3. Patients who are unable to tolerate surgery or do not want to receive surgical treatment; 4. Patients who participate in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
Duration of operation;Intraoperative blood loss;Intraoperative complications;

Secondary

MeasureTime frame
Subsequent pregnancy within 2 years;Recurrent caesarean scar pregnancy in a subsequent pregnancy;Complications in a subsequent pregnancy;Subsequent infertility;Association of above outcomes and the treatment option;

Countries

China

Contacts

Public ContactYunhui Tang

Obstetrics and Gynecology Hospital Affiliated to Fudan University

945808953@qq.com+86 13817987805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026